Place · Level 3
Melatonin
全球年销 $1.5B+ · 天然睡眠激素营销 · 但商业剂量 5-10 mg 远超有效剂量 0.3 mg · 真适应症窄
Story path
- 1Pineal synthesis · dark signalPineal synthesis · dark signal
- 20.3 mg vs 5-10 mg · dose myth0.3 mg vs 5-10 mg · dose myth
- 3Jet lag + shift work · best indicationJet lag + shift work · best indication
- 4Label chaos + commercial issuesLabel chaos + commercial issues
- 5Stronger interventions than melatoninStronger interventions than melatonin
- 6Summary · should I take itSummary · should I take it
Chapter 1
Pineal synthesis · dark signal
Pineal synthesis · dark signal
Melatonin is the body's own 'nighttime signal' hormone, secreted mainly by the pineal gland deep in the brain.
Synthesis chain: Tryptophan → 5-hydroxytryptophan → serotonin (5-HT) → N-acetylserotonin → melatonin. The key enzyme is AANAT (aralkylamine N-acetyltransferase), regulated by the circadian clock.
The control switch is the suprachiasmatic nucleus: The brain's master clock — set by light, it runs the body's day–night rhythm. (suprachiasmatic nucleus): retinal ipRGCs (containing melanopsin) sense blue light (~480 nm). During the day the SCN suppresses AANAT and melatonin is low; in darkness the SCN releases suppression, AANAT is upregulated, and melatonin surges.
Typical rhythm:
Daytime plasma <10 pg/mL9–10 pm starts rising (Dim Light Melatonin Onset, DLMO)2–4 am peak ~80–200 pg/mL (higher in children, much lower in the elderly)Returns to baseline by 6–7 am
Real role in sleep chemistry
Melatonin doesn't directly make you fall asleep — it signals to the body that 'it's now night'. Sleep itself is the combined effect of adenosine, sleep pressure, and the circadian clock. Melatonin's actual job is phase-shifting the body clock, dropping core temperature 0.3–0.5°C, and weakening the wake drive.
What aging and modern life do to it
After age 30, peak melatonin drops ~10–15% per decade — a 70-year-old has only one-third of a 25-year-old's peak. Modern blue-light exposure (phones, computers, LEDs) does the same: 1–2 hours of evening screen time can delay DLMO 1–3 hours and lower peak amplitude 20–50%. This explains why modern people have widely disrupted sleep rhythms, why the elderly struggle to fall asleep, and why blue-light glasses or phone night mode actually make sense.
One common misconception: 'more serotonin = better sleep' is only half right. Serotonin is melatonin's precursor, but supplementing serotonin or tryptophan alone won't significantly raise melatonin, because other regulatory steps gate the path.
Synthesis chain: Tryptophan → 5-hydroxytryptophan → serotonin (5-HT) → N-acetylserotonin → melatonin. The key enzyme is AANAT (aralkylamine N-acetyltransferase), regulated by the circadian clock.
The control switch is the suprachiasmatic nucleus: The brain's master clock — set by light, it runs the body's day–night rhythm. (suprachiasmatic nucleus): retinal ipRGCs (containing melanopsin) sense blue light (~480 nm). During the day the SCN suppresses AANAT and melatonin is low; in darkness the SCN releases suppression, AANAT is upregulated, and melatonin surges.
Typical rhythm:
Daytime plasma <10 pg/mL9–10 pm starts rising (Dim Light Melatonin Onset, DLMO)2–4 am peak ~80–200 pg/mL (higher in children, much lower in the elderly)Returns to baseline by 6–7 am
Real role in sleep chemistry
Melatonin doesn't directly make you fall asleep — it signals to the body that 'it's now night'. Sleep itself is the combined effect of adenosine, sleep pressure, and the circadian clock. Melatonin's actual job is phase-shifting the body clock, dropping core temperature 0.3–0.5°C, and weakening the wake drive.
What aging and modern life do to it
After age 30, peak melatonin drops ~10–15% per decade — a 70-year-old has only one-third of a 25-year-old's peak. Modern blue-light exposure (phones, computers, LEDs) does the same: 1–2 hours of evening screen time can delay DLMO 1–3 hours and lower peak amplitude 20–50%. This explains why modern people have widely disrupted sleep rhythms, why the elderly struggle to fall asleep, and why blue-light glasses or phone night mode actually make sense.
One common misconception: 'more serotonin = better sleep' is only half right. Serotonin is melatonin's precursor, but supplementing serotonin or tryptophan alone won't significantly raise melatonin, because other regulatory steps gate the path.
Blue light · screens · modern sleep debt
The real mechanism behind 'screens hurt sleep' isn't 'tired eyes' — it's chemistry.ipRGC melanopsin is a special class of retinal ganglion cells (non-visual, 1–2% of total) most sensitive to 460–480 nm blue light. They don't form images — they project directly to the suprachiasmatic nucleus: The brain's master clock — set by light, it runs the body's day–night rhythm. and accessory optic nuclei. This pathway IS the light-circadian path.
Blue-light signature of modern screens:
Phone and tablet LCD displays: blue peak ~450 nm, exactly hitting melanopsin's most sensitive bandOffice LED cool white is similar2 hours of screen exposure between 9–11 pm → SCN gets a 'still daytime' signal → AANAT suppressed → melatonin secretion delayed 1–3 hours
Chang 2015 PNAS classic RCT (N=12 healthy adults, crossover design): tablet reading vs paper reading for 5 nights × 4 hours each — tablet group melatonin secretion ↓55%, sleep onset delayed, morning alertness reduced.
Practical countermeasures (ranked by effect):
1. Stop screens 1–2 hours before bed — the strongest single intervention
2. Enable phone Night Shift / f.lux — about 50% blue-light reduction
3. Blue-blocker glasses (orange/yellow) — must actually block 480 nm, not just a 'slightly yellow' gimmick
4. Warm indoor lighting (2700–3000 K) instead of cool white
5. Morning 10 minutes of bright light — opposite of evening, anchors the SCN to 'daytime'
Dimming the screen helps a little (less intensity), but shifting color temperature is more effective (less blue band).
Children + screens + insomnia: children have higher melanopsin sensitivity and are more affected by blue light. The AAP recommends no screens under age 2, and screen-free for 1 hour before bed in school-age children. The surge in childhood and teen insomnia rates correlates directly with screen exposure (Carter 2016 *JAMA Pediatr* meta).
Chapter 2
0.3 mg vs 5-10 mg · dose myth
0.3 mg vs 5-10 mg · dose myth
Melatonin is the most ironic 'more is better' counter-example in nutritional medicine.
The physiological peak is plasma 80–200 pg/mL between 2–4 am. Looking at the RCT data, the effective dose is in fact very low:
0.3 mg oral is already close to physiological peak — enough to induce sleep and shift the circadian phase0.1–0.5 mg: in Zhdanova 2001 *JCEM* (30 age-related insomniacs, comparing 0.1 / 0.3 / 3.0 mg), 0.3 mg was most effective. (Note: Zhdanova 1995 MIT was a dose-response study in healthy young adults — these are two different papers; don't conflate them.)3 mg+: blood levels 10–50× supraphysiological — similar effect to lower doses initially, but more side effects5–10 mg: 50–200× supraphysiological — most RCTs show nitric oxide: A small signal molecule from the vessel lining that relaxes the vessel-wall muscle so the vessel widens. better effect, and more next-day drowsiness, headache, and endocrine disruption
Why are commercial products all 3–10 mg? Several reasons stack:
1. Historical accident — 1990s early products were dosed by 'feels like a pill', not by RCTs
2. The consumer expectation that 'more = safer'
3. Patent protection expired long ago — manufacturers differentiate by dose and packaging
4. 'Stronger action' marketing — empirically false
Why high doses may actually be worse:
Blood concentration too high → next-day residue, presenting as drowsiness, headache, a 'melatonin hangover' feelingMelatonin receptors (MT1/MT2) downregulate; chronic high-dose use may cause toleranceHormone interference — melatonin interacts with the LH/FSH/sex hormone axis; large doses may affect puberty or menstruation5+ mg side effects include vivid dreams, hypothermia, short-term mood changes
How to pick a dose:
Healthy adult under 40 + occasional jet lag: 0.3–0.5 mg, 30–60 min pre-bedChronic insomnia + 60+ elderly: start at 0.5–1 mg, observeChildren (clinical use): 0.5–2 mg under MD guidance, not dailySpecial scenarios (blind, severe circadian disorder): prescription dose + medical supervision, may be higher
4-week trial protocol:
1. 0.3 mg × 30 min pre-bed × 1 week
2. No effect, raise to 0.5 mg × 1 week
3. Still no effect, raise to 1 mg × 1 week
4. 1 mg still no effect — this is not a dose problem, it's an indication problem; see a doctor instead of escalating further
The physiological peak is plasma 80–200 pg/mL between 2–4 am. Looking at the RCT data, the effective dose is in fact very low:
0.3 mg oral is already close to physiological peak — enough to induce sleep and shift the circadian phase0.1–0.5 mg: in Zhdanova 2001 *JCEM* (30 age-related insomniacs, comparing 0.1 / 0.3 / 3.0 mg), 0.3 mg was most effective. (Note: Zhdanova 1995 MIT was a dose-response study in healthy young adults — these are two different papers; don't conflate them.)3 mg+: blood levels 10–50× supraphysiological — similar effect to lower doses initially, but more side effects5–10 mg: 50–200× supraphysiological — most RCTs show nitric oxide: A small signal molecule from the vessel lining that relaxes the vessel-wall muscle so the vessel widens. better effect, and more next-day drowsiness, headache, and endocrine disruption
Why are commercial products all 3–10 mg? Several reasons stack:
1. Historical accident — 1990s early products were dosed by 'feels like a pill', not by RCTs
2. The consumer expectation that 'more = safer'
3. Patent protection expired long ago — manufacturers differentiate by dose and packaging
4. 'Stronger action' marketing — empirically false
Why high doses may actually be worse:
Blood concentration too high → next-day residue, presenting as drowsiness, headache, a 'melatonin hangover' feelingMelatonin receptors (MT1/MT2) downregulate; chronic high-dose use may cause toleranceHormone interference — melatonin interacts with the LH/FSH/sex hormone axis; large doses may affect puberty or menstruation5+ mg side effects include vivid dreams, hypothermia, short-term mood changes
How to pick a dose:
Healthy adult under 40 + occasional jet lag: 0.3–0.5 mg, 30–60 min pre-bedChronic insomnia + 60+ elderly: start at 0.5–1 mg, observeChildren (clinical use): 0.5–2 mg under MD guidance, not dailySpecial scenarios (blind, severe circadian disorder): prescription dose + medical supervision, may be higher
4-week trial protocol:
1. 0.3 mg × 30 min pre-bed × 1 week
2. No effect, raise to 0.5 mg × 1 week
3. Still no effect, raise to 1 mg × 1 week
4. 1 mg still no effect — this is not a dose problem, it's an indication problem; see a doctor instead of escalating further
RCT evidence for 'right dose'
Putting the key RCT data side by side makes the picture clear.Zhdanova 2001 (*JCEM*) — age-related insomnia dose-response classic: N=30 elderly insomniacs comparing 0.1 / 0.3 / 3.0 mg vs placebo. 0.3 mg was most effective at restoring sleep efficiency; 3.0 mg produced supraphysiological peaks + next-day residue + elevated drowsiness scores. Conclusion: 0.3 mg is the best balance of effect and side effects. (The 1995 Zhdanova MIT paper studied healthy young adults — different study, do not conflate.)
Brzezinski 2005 *Sleep Med Rev* meta-analysis (17 RCTs, N=284):
Objective sleep onset latency shortened ~4 minutesTotal sleep time increased ~12–13 minutesSleep efficiency improved 2–3%Effect small but stable, weaker than hypnotics (zolpidem cuts latency by 22 minutes)No dose-response relationship beyond 0.3 mg
Auger AASM 2015 clinical practice guideline: circadian sleep-wake disorders (blind, delayed phase, jet lag) — specialty first-line; general adult insomnia — not recommended as first choice (small effect); behavioral therapy (CBT-I) is first-line. Dose 0.5–3 mg, no higher. Timing depends on diagnosis: jet lag or delayed phase, 30 min pre-bed; advanced phase, morning dosing.
Herxheimer 2002 Cochrane meta (jet lag prevention): crossing 5+ time zones improves ~50% effective rate; 0.5–5 mg all effective, 1–3 mg optimal. Jet lag is one of melatonin's strongest indications.
Clinical evidence for melatonin in children:
Autism insomnia: 0.5–3 mg, AAP-acknowledgedADHD with comorbid insomnia: similar dosesHealthy children 'trouble falling asleep': not recommended, behavioral intervention firstUS melatonin gummy sales for kids have exploded, and ER poisoning cases have risen 5× (CDC 2022). Not the melatonin itself but the combination of candy-style packaging, high doses, and easy overdose
Summary:
'More is better' is wrong; 0.3–1 mg is already the plateau'Insurance-style every night' has no evidence — possible tolerance plus endocrine interferenceFor jet lag or specific circadian disorders it works, but only with the right dose at the right time
Chapter 3
Jet lag + shift work · best indication
Jet lag + shift work · best indication
Melatonin's two most-evidenced uses are jet lag and shift-work adjustment — but most people get the 'how' wrong.
Jet lag
Core concept: melatonin is a circadian phase-shifter, not a sedative. The key question before taking it is 'do I need to advance or delay my clock?'
Advance: flying east (Beijing → NYC, need earlier sleep/wake)Delay: flying west (Beijing → SF, need later sleep/wake)Taking it at the wrong time = reversed effect
For eastward flights (3+ time zones):
2–3 days before departure, take 0.5–3 mg in the destination-time afternoon/duskAfter arrival, take 30–60 min before local bedtime for 2–3 nightsPair with bright-light exposure in the morning after arrival (opposite action of melatonin)
For westward flights:
Most don't need melatonin — natural delay is easierSevere cases can dose on predawn waking after arrival (delaying phase) — not routine
Herxheimer 2002 Cochrane: crossing 5+ time zones, RCT effective rate ~50% (improves 1–2 days of recovery time); <5 zones, effect is small.
Shift work
This is a complex and painful clinical scenario; melatonin can only help to a limited extent:
Post-night-shift daytime sleep: 1–3 mg on the morning return helps extend daytime sleepWeekend reverse: transitions are chaotic, melatonin is adjunct, light management is primaryPermanent night vs rotating night: rotating is harder to adjustRecommend negotiating at least 3 weeks of stable shifts with the employer, then building a reversed circadian
General insomnia ≠ jet lag / shift work
The first-line treatment for chronic insomnia is CBT-I (cognitive behavioral therapy): multiple RCTs show its long-term efficacy exceeds any drug, and APA and AASM both recommend it as first-line. Melatonin has a small effect for general insomnia and is not first-choice. Subtyping further:
Trouble falling asleep: possibly delayed sleep phase disorder (DSPD) — melatonin useful, but needs proper diagnosisEarly waking: advanced sleep phase disorder (ASPD) — morning melatonin, a rare use caseMultiple awakenings: melatonin barely works — investigate apnea, anxiety, nocturia
So 90% of people 'just popping melatonin' are using it wrong — jet lag and specific circadian disorders are its strengths, treating general insomnia is its weakness.
Jet lag
Core concept: melatonin is a circadian phase-shifter, not a sedative. The key question before taking it is 'do I need to advance or delay my clock?'
Advance: flying east (Beijing → NYC, need earlier sleep/wake)Delay: flying west (Beijing → SF, need later sleep/wake)Taking it at the wrong time = reversed effect
For eastward flights (3+ time zones):
2–3 days before departure, take 0.5–3 mg in the destination-time afternoon/duskAfter arrival, take 30–60 min before local bedtime for 2–3 nightsPair with bright-light exposure in the morning after arrival (opposite action of melatonin)
For westward flights:
Most don't need melatonin — natural delay is easierSevere cases can dose on predawn waking after arrival (delaying phase) — not routine
Herxheimer 2002 Cochrane: crossing 5+ time zones, RCT effective rate ~50% (improves 1–2 days of recovery time); <5 zones, effect is small.
Shift work
This is a complex and painful clinical scenario; melatonin can only help to a limited extent:
Post-night-shift daytime sleep: 1–3 mg on the morning return helps extend daytime sleepWeekend reverse: transitions are chaotic, melatonin is adjunct, light management is primaryPermanent night vs rotating night: rotating is harder to adjustRecommend negotiating at least 3 weeks of stable shifts with the employer, then building a reversed circadian
General insomnia ≠ jet lag / shift work
The first-line treatment for chronic insomnia is CBT-I (cognitive behavioral therapy): multiple RCTs show its long-term efficacy exceeds any drug, and APA and AASM both recommend it as first-line. Melatonin has a small effect for general insomnia and is not first-choice. Subtyping further:
Trouble falling asleep: possibly delayed sleep phase disorder (DSPD) — melatonin useful, but needs proper diagnosisEarly waking: advanced sleep phase disorder (ASPD) — morning melatonin, a rare use caseMultiple awakenings: melatonin barely works — investigate apnea, anxiety, nocturia
So 90% of people 'just popping melatonin' are using it wrong — jet lag and specific circadian disorders are its strengths, treating general insomnia is its weakness.
CBT-I · the real first-line for insomnia
Why don't most doctors reach for melatonin first? Because there's a stronger option — CBT-I (Cognitive Behavioral Therapy for Insomnia). It has six components.① Sleep restriction — the most counterintuitive but strongest:
Compress time in bed to actual sleep time, raising sleep efficiencyExample: bed at 11 pm, sleep at 1 am, wake at 6 am — 5 h sleep but 7 h in bedPrescription: time in bed = 5 hours, bed at 1 am, wake at 6 amSustain 1–2 weeks: sleep pressure accumulates, onset speeds up, efficiency risesThen relax by 15 min/week toward the optimum
② Stimulus control:
Bed is for sleep and sex only — no phone, work, or TV in bedAfter 20 minutes not asleep, get up, do something boring, return when sleepyRebuild the 'bed = sleep' conditioned reflex
③ Sleep hygiene: room 18–20°C; absolute darkness and quiet; same wake time every day even after a bad night; caffeine cutoff at 2 pm; avoid alcohol (disrupts REM); screens off 1–2 hours before bed.
④ Cognitive restructuring: the belief 'I MUST get 8 hours tonight' is the strongest catalyst of insomnia. Rewrite it as 'a bad night doesn't mean I can't function tomorrow' to break the sleep-anxiety → worse-sleep cycle.
⑤ Relaxation training: progressive muscle relaxation, mindfulness meditation, 4-7-8 breathing. The goal is not 'pre-bed relaxation' but reducing daytime hyperarousal.
⑥ Paradoxical intention (advanced): deliberately try to stay awake — releases the 'I must sleep' pressure.
RCT evidence: multiple meta-analyses show CBT-I is as effective as the strongest hypnotics (zolpidem), and superior long-term. AASM, APA, NICE, and WHO all recommend it as first-line for chronic insomnia; digital versions (Sleepio, SHUTi) are FDA-approved.
So 'using melatonin for chronic insomnia' before trying CBT-I means missing the stronger option. The reasonable path is CBT-I first, with short-term melatonin as adjunct if needed.
Chapter 4
Label chaos + commercial issues
Label chaos + commercial issues
Erland 2017 JCSM sampling tested 31 commercial melatonin products in Canada:
Label vs actual content differed -83% to +478%70% of products were off by ≥10%26% contained unlabeled 5-HT (serotonin) — users might unknowingly be taking serotonin too, with risk of serotonin syndromeChildren's gummies labeled 1 mg sometimes contained 4 mg or more
FDA / NMPA / Health Canada inconsistent regulation:
USA: classified as dietary supplement, no FDA approval needed — label accuracy and purity left to manufacturer self-policingCanada: NHP (Natural Health Product) registered, stricter than USMost EU countries: prescription medication, not OTC — starts at 1 mg, requires MD prescriptionAustralia: prescriptionChina: classified as health food — labels more regulated but content consistency variesJapan: not allowed to be sold as a supplement
This means the same '3 mg melatonin capsule' bought at a US supermarket vs a European pharmacy may not be the same product at all — purity, dose, accessory ingredients, and clinical supervision all differ.
US ER poisoning surge: CDC 2022 MMWR data show pediatric melatonin poisoning calls rose 530% from 2012–2021, driven by gummy formulation + high dose (5–10 mg) + candy-style packaging. Children who ingest gummies are taken to the ER; most recover, but some need hospitalization or ICU.
Long-term use unknowns:
RCT data beyond 12 weeks is scarceLong-term effect on puberty and sexual development in children is unknown; concern stems from interaction with the reproductive hormone axisTolerance: some users report needing gradual escalation, RCT data are inconsistentDependence and withdrawal: psychological dependence is common, abrupt cessation may produce rebound insomnia
The boundary of 'safe':
Healthy adult, occasional use, <5 mg, <2 weeks: virtually no serious side effectsLong-term nightly 5+ mg: boundary unclear, concern exceeds evidenceChildren, pregnant women, teens: MD-guided, short-term, only when neededPeople on anticoagulants, antihypertensives, immunosuppressants, or antiepileptics: caution due to theoretical interactions
Label vs actual content differed -83% to +478%70% of products were off by ≥10%26% contained unlabeled 5-HT (serotonin) — users might unknowingly be taking serotonin too, with risk of serotonin syndromeChildren's gummies labeled 1 mg sometimes contained 4 mg or more
FDA / NMPA / Health Canada inconsistent regulation:
USA: classified as dietary supplement, no FDA approval needed — label accuracy and purity left to manufacturer self-policingCanada: NHP (Natural Health Product) registered, stricter than USMost EU countries: prescription medication, not OTC — starts at 1 mg, requires MD prescriptionAustralia: prescriptionChina: classified as health food — labels more regulated but content consistency variesJapan: not allowed to be sold as a supplement
This means the same '3 mg melatonin capsule' bought at a US supermarket vs a European pharmacy may not be the same product at all — purity, dose, accessory ingredients, and clinical supervision all differ.
US ER poisoning surge: CDC 2022 MMWR data show pediatric melatonin poisoning calls rose 530% from 2012–2021, driven by gummy formulation + high dose (5–10 mg) + candy-style packaging. Children who ingest gummies are taken to the ER; most recover, but some need hospitalization or ICU.
Long-term use unknowns:
RCT data beyond 12 weeks is scarceLong-term effect on puberty and sexual development in children is unknown; concern stems from interaction with the reproductive hormone axisTolerance: some users report needing gradual escalation, RCT data are inconsistentDependence and withdrawal: psychological dependence is common, abrupt cessation may produce rebound insomnia
The boundary of 'safe':
Healthy adult, occasional use, <5 mg, <2 weeks: virtually no serious side effectsLong-term nightly 5+ mg: boundary unclear, concern exceeds evidenceChildren, pregnant women, teens: MD-guided, short-term, only when neededPeople on anticoagulants, antihypertensives, immunosuppressants, or antiepileptics: caution due to theoretical interactions
4 product criteria
If you must buy, there are 4 selection criteria.1. Dose ≤ 1 mg: start at 0.3–0.5 mg; avoid '5–10 mg' and 'high-strength' products. If hard to find, a pill cutter on a 1 mg tablet gives ~0.25 mg — a workable compromise.
2. Third-party certification (USP / NSF / ConsumerLab): a USP Verified mark means actual content matches the label, no heavy metals, GMP-compliant; ConsumerLab.com is a paid subscription but its testing is credible; NSF Certified for Sport is athlete-grade. Uncertified products are likely to produce Erland 2017-type problems — unreliable.
3. Clean ingredient list:
What you want: melatonin + minimal excipients (cellulose, magnesium stearate)What to avoid: 'sleep blends' mixing multiple sleep agents (cAMP / GABA / 5-HTP / passionflower / valerian, etc.) — synergy is unverified and side-effect risks stackEspecially avoid blends containing 5-HTP (5-hydroxytryptophan) — this is the source of the 'unlabeled serotonin' problem found by Erland
4. Form and timing:
Sublingual tablets or sprays: fast absorption, short half-life, good for trouble falling asleepExtended-release: for multiple awakenings, mimics natural peak curveGummies: usually high-dose and easy to overdose — keep out of children's reachTiming: 30–60 min pre-bed, not right at bedtime — it needs time to work
Large brands like Costco Kirkland, Nature Made, and Pure Encapsulations are generally better quality with third-party testing; be wary of 'influencer / overseas haul / livestream' products.
Practical recommendations for healthy adults:
First try: Pure Encapsulations 0.5 mg capsuleJet lag: Life Extension 0.3 mg sublingualChildren (MD-guided): Natrol Kids 1 mg, avoid gummiesEU users: ask a doctor for Circadin (prescription 2 mg extended-release)
The long-term goal is NOT chronic dependence — rebuild your circadian via light exposure, fixed schedule, and CBT-I, demoting melatonin to 'emergency use'.
Chapter 5
Stronger interventions than melatonin
Stronger interventions than melatonin
Ranking sleep improvements by RCT-evidence ROI.
A-tier (strong RCT, large effect)
1. Behavioral therapy (CBT-I): far exceeds any supplement or single behavioral intervention. Sleep onset ↓50%, total sleep time ↑30–60 min, long-term (1–3 yr) durable — opposite of drugs. Digital versions (Sleepio, SHUTi) also effective.
2. Fixed wake time (circadian anchor): more important than bedtime. Same wake time every day, weekend drift <1 h — sleep pressure and circadian align, auto-tuning sleep onset.
3. Morning 10–30 min bright light exposure: outdoor > indoor (10000+ vs ~500 lux). suprachiasmatic nucleus: The brain's master clock — set by light, it runs the body's day–night rhythm. anchors 'morning', then melatonin appears automatically 14–16 hours later. Northern winter or indoor workers can use a lightbox (10000 lux × 30 min) instead.
4. Bedroom 18–20°C: core body temperature must drop to fall asleep. Too warm is the most common but overlooked cause of insomnia. A cooling mattress, fan, or AC at 18–19°C beats any supplement.
5. Caffeine cutoff at 2 pm: half-life 5–7 hours (slow CYP1A2 metabolizers 9–12 h). Coffee at 4 pm → 50% still in your body at 11 pm, disturbing deep sleep. 'I can fall asleep with coffee' doesn't equal 'good sleep quality' — deep sleep duration is often impaired.
B-tier (moderate RCT)
6. Regular aerobic exercise: 30+ min/day, not within 2–3 hours pre-bed. Multiple meta-analyses show effects comparable to mild hypnotics for chronic insomnia.
7. Limit alcohol: alcohol makes you fall asleep faster but significantly disrupts late-night REM and deep sleep. Habitual drinking accumulates chronic sleep debt.
8. End meals 3 hours pre-bed + limit fluids: digestion disturbs deep sleep, nocturia disturbs the whole night.
9. Bedroom absolutely dark and quiet: even the dim glow of an LED bulb can disturb melatonin. Earplugs, eye mask, blackout curtains.
C-tier (limited evidence + supplements)
Magnesium (citrate/glycinate, 200–400 mg): effective if deficient, small effect if repleteGlycine (3 g pre-bed): small RCTs show subjective improvementL-theanine (200 mg): 'relaxed without drowsy', good for pre-sleep anxietyValerian: mixed data, traditional in EuropeMelatonin (0.3–1 mg): first-line for jet lag and specific circadian disorders, small effect for general insomnia
Trendy/expensive supplements:
CBD: weak RCT data5-HTP: serotonin syndrome risk, do not self-supplementGABA supplements: GABA doesn't cross the blood-brain barrier, oral is essentially useless'Sleep blend' supplements: multiple ingredients, side-effect risks stack
Core wisdom: most 'insomnia' comes from modern anti-circadian habits. Fixing behavior and environment far outweighs any supplement, including melatonin itself.
A-tier (strong RCT, large effect)
1. Behavioral therapy (CBT-I): far exceeds any supplement or single behavioral intervention. Sleep onset ↓50%, total sleep time ↑30–60 min, long-term (1–3 yr) durable — opposite of drugs. Digital versions (Sleepio, SHUTi) also effective.
2. Fixed wake time (circadian anchor): more important than bedtime. Same wake time every day, weekend drift <1 h — sleep pressure and circadian align, auto-tuning sleep onset.
3. Morning 10–30 min bright light exposure: outdoor > indoor (10000+ vs ~500 lux). suprachiasmatic nucleus: The brain's master clock — set by light, it runs the body's day–night rhythm. anchors 'morning', then melatonin appears automatically 14–16 hours later. Northern winter or indoor workers can use a lightbox (10000 lux × 30 min) instead.
4. Bedroom 18–20°C: core body temperature must drop to fall asleep. Too warm is the most common but overlooked cause of insomnia. A cooling mattress, fan, or AC at 18–19°C beats any supplement.
5. Caffeine cutoff at 2 pm: half-life 5–7 hours (slow CYP1A2 metabolizers 9–12 h). Coffee at 4 pm → 50% still in your body at 11 pm, disturbing deep sleep. 'I can fall asleep with coffee' doesn't equal 'good sleep quality' — deep sleep duration is often impaired.
B-tier (moderate RCT)
6. Regular aerobic exercise: 30+ min/day, not within 2–3 hours pre-bed. Multiple meta-analyses show effects comparable to mild hypnotics for chronic insomnia.
7. Limit alcohol: alcohol makes you fall asleep faster but significantly disrupts late-night REM and deep sleep. Habitual drinking accumulates chronic sleep debt.
8. End meals 3 hours pre-bed + limit fluids: digestion disturbs deep sleep, nocturia disturbs the whole night.
9. Bedroom absolutely dark and quiet: even the dim glow of an LED bulb can disturb melatonin. Earplugs, eye mask, blackout curtains.
C-tier (limited evidence + supplements)
Magnesium (citrate/glycinate, 200–400 mg): effective if deficient, small effect if repleteGlycine (3 g pre-bed): small RCTs show subjective improvementL-theanine (200 mg): 'relaxed without drowsy', good for pre-sleep anxietyValerian: mixed data, traditional in EuropeMelatonin (0.3–1 mg): first-line for jet lag and specific circadian disorders, small effect for general insomnia
Trendy/expensive supplements:
CBD: weak RCT data5-HTP: serotonin syndrome risk, do not self-supplementGABA supplements: GABA doesn't cross the blood-brain barrier, oral is essentially useless'Sleep blend' supplements: multiple ingredients, side-effect risks stack
Core wisdom: most 'insomnia' comes from modern anti-circadian habits. Fixing behavior and environment far outweighs any supplement, including melatonin itself.
'3-day sleep reset' protocol
If your sleep is bad, here is a no-supplement 3-day reset.Day 1 · Unplug + anchor wake time
After 8 pm, no overhead lights — use table lamp with warm-color bulbs9 pm TV off, phone away10 pm set bedroom to 18–19°CDon't check the time; turn the alarm clock aroundTomorrow's wake time = your weekday wake time, even on a weekend
Day 2 · Morning light + no makeup sleep
Within 30 minutes of waking, get 10–20 minutes of outdoor light (overcast still >1000 lux outdoors)No makeup sleep, no matter how poorly you slept the night beforeNaps <30 minutes, never after 2 pmNo caffeine after 2 pmDinner 6–7 pm, then water onlyScreens off by 9 pmBed at 10:30
Day 3 · Consolidate + assess
Repeat Day 2's protocolLog three things each night: time you fell asleep, number of awakenings, how you felt in the morningImprovement ≥30%: continue the pattern 2 weeks — 80% of insomniacs improve significantlyNo improvement: workup OSA (snoring, daytime fatigue), or see a doctor for CBT-I or psychiatric evaluation
Key principles:
No reliance on supplements or drugsBehavior first, not 'pop a pill at night'Morning light is the single strongest interventionFixed wake time matters more than fixed bedtime
Why is this stronger than 5 mg melatonin? Because melatonin tunes only one variable (the signal), while insomnia is usually a multi-variable problem (circadian + hygiene + environment + psychology). One pill can't fix 6 variables.
Chapter 6
Summary · should I take it
Summary · should I take it
Practical decision checklist for melatonin.
Suitable (consider 0.3–1 mg, 30–60 min pre-bed):
Jet lag across 5+ time zones: strongest indicationLong-term shift work: paired with light managementDiagnosed delayed sleep phase disorder (DSPD): MD-guidedBlind non-24-hour rhythm disorder: strong evidence, FDA-approved Hetlioz (prescription)65+ elderly + low endogenous melatonin + insomnia: a 1 mg trial is worthwhileAutism / ADHD children with comorbid insomnia: MD-guided, 0.5–3 mg
Not suitable:
'Insurance-style every night' healthy adults: no evidence, possible tolerance or dependenceChronic insomnia without CBT-I trial: missing the stronger optionHealthy children with 'trouble falling asleep': behavioral intervention, not gummiesPregnancy and lactation: insufficient safety data, use cautionPatients on anticoagulants, antihypertensives, antiepileptics, or immunosuppressants: interaction riskMixed insomnia (onset + early + multiple wakings): melatonin barely works — find the causeDepression or anxiety diagnosis with insomnia as a symptom: treat the primary condition, not melatonin
Dose principles:
Start 0.3–0.5 mg (rational low dose)Up to 1 mg if neededRarely exceed 3 mg (loses dose-response)Absolutely avoid 5–10 mg 'strong' products (no benefit, more side effects)
Timing:
Most indications: 30–60 minutes before bedJet lag: destination-local bedtime after arrivalDSPD: 3–5 hours before habitual bedtimeShift work: before planned sleep
Relationship to other interventions: pre-bed blue-light exposure causes more damage than melatonin can repair; stop screens first. Morning light + fixed wake time > melatonin. Bedroom environment and bedding > melatonin. The first-line treatment for chronic insomnia is always a 6–8 week course of CBT-I.
Handling long-term use:
2–4 weeks: reassess whether you still need it3 months: re-evaluate, most should shift to behavioral approachesBeyond 6 months continuous nightly use: not recommended, RCT data is void
Final line: melatonin is NOT a 'sleep hormone supplement' — it's a circadian phase shifter. Used in the right scenario at the right dose, it works; treated as a universal sleep aid, it disappoints.
Suitable (consider 0.3–1 mg, 30–60 min pre-bed):
Jet lag across 5+ time zones: strongest indicationLong-term shift work: paired with light managementDiagnosed delayed sleep phase disorder (DSPD): MD-guidedBlind non-24-hour rhythm disorder: strong evidence, FDA-approved Hetlioz (prescription)65+ elderly + low endogenous melatonin + insomnia: a 1 mg trial is worthwhileAutism / ADHD children with comorbid insomnia: MD-guided, 0.5–3 mg
Not suitable:
'Insurance-style every night' healthy adults: no evidence, possible tolerance or dependenceChronic insomnia without CBT-I trial: missing the stronger optionHealthy children with 'trouble falling asleep': behavioral intervention, not gummiesPregnancy and lactation: insufficient safety data, use cautionPatients on anticoagulants, antihypertensives, antiepileptics, or immunosuppressants: interaction riskMixed insomnia (onset + early + multiple wakings): melatonin barely works — find the causeDepression or anxiety diagnosis with insomnia as a symptom: treat the primary condition, not melatonin
Dose principles:
Start 0.3–0.5 mg (rational low dose)Up to 1 mg if neededRarely exceed 3 mg (loses dose-response)Absolutely avoid 5–10 mg 'strong' products (no benefit, more side effects)
Timing:
Most indications: 30–60 minutes before bedJet lag: destination-local bedtime after arrivalDSPD: 3–5 hours before habitual bedtimeShift work: before planned sleep
Relationship to other interventions: pre-bed blue-light exposure causes more damage than melatonin can repair; stop screens first. Morning light + fixed wake time > melatonin. Bedroom environment and bedding > melatonin. The first-line treatment for chronic insomnia is always a 6–8 week course of CBT-I.
Handling long-term use:
2–4 weeks: reassess whether you still need it3 months: re-evaluate, most should shift to behavioral approachesBeyond 6 months continuous nightly use: not recommended, RCT data is void
Final line: melatonin is NOT a 'sleep hormone supplement' — it's a circadian phase shifter. Used in the right scenario at the right dose, it works; treated as a universal sleep aid, it disappoints.
Real effect vs placebo recognition
How to tell whether melatonin really works for you.Objective marker: sleep onset latency <30 min (vs your baseline)Subjective feel: morning alert, not drowsySustained for over a week — not a one-night 'good mood made me sleep' effect
Signature of placebo effect: the expectation 'tonight I will sleep' reduces anxiety, which naturally lets you fall asleep; ANY pill produces about 30% subjective improvement; but this effect isn't durable and fades once the novelty wears off.
Signs that it's really working:
Cross-time-zone use (the mechanism makes sense)Specific circadian disorder + correct timing65+ with naturally low endogenous melatonin≥4 weeks sustained improvementSymptoms return after stopping (not 'withdrawal', but the underlying indication persisting)
Self-assessment questions:
1. Trouble falling asleep, or multiple awakenings? Trouble falling asleep — melatonin may help; multiple awakenings — barely
2. Late-sleep-late-rise, or fatigued all day? Late-sleep-late-rise (DSPD) → melatonin + morning light; all-day fatigue → workup OSA, hypothyroid, depression, iron, B12
3. Sleep only 5–6 hours and not tired? Some genotypes need only 6 hours (short sleep syndrome, ~1–3% of people) — not a disease, no treatment needed
Clear signals to stop melatonin:
4 weeks of use, no subjective changeEscalated to 3 mg+ and still no effectNext-day drowsiness, headache, or low mood appearsVivid nightmares clearly increaseTachycardia or palpitationsConflict with required medications (warfarin, etc.)
When you find it 'doesn't work', don't keep escalating — return to behavioral basics and investigate the real cause of your sleep problem. A single pill can't fix an environmental, circadian, psychological, and physiological multi-factor disorder.